Literature DB >> 18338303

Disease surveillance and nonprescription medication sales can predict increases in poison exposure.

Edward Krenzelok1, Erma MacPherson, Rita Mrvos.   

Abstract

INTRODUCTION: Real-time Outbreak and Disease Surveillance (RODS) is a national real-time syndromic surveillance system that classifies hospital registration chief complaints into one of seven syndromic categories. The National Retail Data Monitor (NRDM) is a public health surveillance tool that is designed to collect and analyze the daily sales of 18 categories of nonprescription medications. The goal of RODS and NRDM is to provide early warning of disease outbreaks, such as biological terrorism. The purpose of this study was to determine whether peak syndromic activity and the consequential purchase of nonprescription medications could predict an increase in poisoning exposures involving NRDM-monitored medications.
METHODS: Data from the RODS and NRDM databases were plotted graphically to portray activity that occurred during 2003. Data from a regional poison information center electronic medical record system that involved all human exposure calls related to NRDM monitored medications in 2003 were extracted and graphed. Analysis included comparisons between the data sets.
RESULTS: Poison center exposure volume correlated predictably and simultaneously with the peak activity in both the RODS and NRDM databases. DISCUSSION: There was no delay between the onset of an influenza outbreak in December 2003, the sale of nonprescription palliative mediations, and the increase in poison center exposure call volume. Increased availability of and access to nonprescription medications resulted in more poisoning exposure calls.
CONCLUSIONS: Real-time surveillance using other databases can help to forecast poison center activity. This knowledge allows the poison center to provide anticipatory guidance to the residents of its region.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18338303      PMCID: PMC3550096          DOI: 10.1007/bf03160942

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  3 in total

1.  National Retail Data Monitor for public health surveillance.

Authors:  Michael M Wagner; F C Tsui; J Espino; W Hogan; J Hutman; J Hersh; D Neill; A Moore; G Parks; C Lewis; R Aller
Journal:  MMWR Suppl       Date:  2004-09-24

2.  Removing a barrier to computer-based outbreak and disease surveillance--the RODS Open Source Project.

Authors:  Jeremy U Espino; M Wagner; C Szczepaniak; F C Tsui; H Su; R Olszewski; Z Liu; W Chapman; X Zeng; L Ma; Z Lu; J Dara
Journal:  MMWR Suppl       Date:  2004-09-24

3.  Syndrome and outbreak detection using chief-complaint data--experience of the Real-Time Outbreak and Disease Surveillance project.

Authors:  Michael M Wagner; J Espino; F C Tsui; P Gesteland; W Chapman; O Ivanov; A Moore; W Wong; J Dowling; J Hutman
Journal:  MMWR Suppl       Date:  2004-09-24
  3 in total
  5 in total

1.  The value and evolving role of the U.S. Poison Control Center System.

Authors:  Henry A Spiller; Jill R K Griffith
Journal:  Public Health Rep       Date:  2009 May-Jun       Impact factor: 2.792

2.  RE-PLAN: An Extensible Software Architecture to Facilitate Disaster Response Planning.

Authors:  Martin O'Neill; Armin R Mikler; Saratchandra Indrakanti; Chetan Tiwari; Tamara Jimenez
Journal:  IEEE Trans Syst Man Cybern Syst       Date:  2014-12       Impact factor: 13.451

3.  Prediction of gastrointestinal disease with over-the-counter diarrheal remedy sales records in the San Francisco Bay Area.

Authors:  Michelle L Kirian; June M Weintraub
Journal:  BMC Med Inform Decis Mak       Date:  2010-07-20       Impact factor: 2.796

4.  Specializing for predicting obesity and its co-morbidities.

Authors:  Ira Goldstein; Ozlem Uzuner
Journal:  J Biomed Inform       Date:  2008-11-11       Impact factor: 6.317

5.  Emergency department syndromic surveillance systems: a systematic review.

Authors:  Helen E Hughes; Obaghe Edeghere; Sarah J O'Brien; Roberto Vivancos; Alex J Elliot
Journal:  BMC Public Health       Date:  2020-12-09       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.